- Home
- THFF vs PCRX Comparison
THFF vs PCRX Comparison
Compare THFF & PCRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- THFF
- PCRX
- Stock Information
- Founded
- THFF 1984
- PCRX 2006
- Country
- THFF United States
- PCRX United States
- Employees
- THFF N/A
- PCRX N/A
- Industry
- THFF Major Banks
- PCRX Biotechnology: Pharmaceutical Preparations
- Sector
- THFF Finance
- PCRX Health Care
- Exchange
- THFF Nasdaq
- PCRX Nasdaq
- Market Cap
- THFF 599.3M
- PCRX 1.2B
- IPO Year
- THFF N/A
- PCRX 2011
- Fundamental
- Price
- THFF $51.22
- PCRX $26.88
- Analyst Decision
- THFF Hold
- PCRX Buy
- Analyst Count
- THFF 1
- PCRX 10
- Target Price
- THFF $45.00
- PCRX $29.30
- AVG Volume (30 Days)
- THFF 46.4K
- PCRX 892.8K
- Earning Date
- THFF 02-11-2025
- PCRX 02-27-2025
- Dividend Yield
- THFF 4.11%
- PCRX N/A
- EPS Growth
- THFF N/A
- PCRX N/A
- EPS
- THFF 4.00
- PCRX N/A
- Revenue
- THFF $201,592,000.00
- PCRX $694,957,000.00
- Revenue This Year
- THFF N/A
- PCRX $5.14
- Revenue Next Year
- THFF $11.39
- PCRX $2.44
- P/E Ratio
- THFF $12.41
- PCRX N/A
- Revenue Growth
- THFF N/A
- PCRX 4.40
- 52 Week Low
- THFF $34.58
- PCRX $11.16
- 52 Week High
- THFF $51.87
- PCRX $31.67
- Technical
- Relative Strength Index (RSI)
- THFF 56.31
- PCRX 77.75
- Support Level
- THFF $47.42
- PCRX $25.06
- Resistance Level
- THFF $49.23
- PCRX $27.10
- Average True Range (ATR)
- THFF 1.35
- PCRX 1.45
- MACD
- THFF 0.26
- PCRX 0.28
- Stochastic Oscillator
- THFF 75.81
- PCRX 86.23
About THFF First Financial Corporation Indiana
First Financial Corp operates as a financial holding company, which is engaged in the provision of financial services in the United States. The company offers a wide variety of financial services including commercial, mortgage, and consumer lending, lease financing, trust account services, depositor services, and insurance services, through its subsidiaries. Its primary source of revenue is derived from loans to customers and investment activities.
About PCRX Pacira BioSciences Inc.
Pacira BioSciences Inc is a provider of non-opioid pain management and regenerative health solutions dedicated to advancing and improving outcomes for healthcare practitioners and their patients. The company has three commercialized non-opioid treatments: EXPAREL a long-acting, local analgesic currently approved for postsurgical pain management; ZILRETTA, an extended-release, intra-articular, corticosteroid injection indicated for the management of osteoarthritis; iovera, a novel, handheld device for delivering immediate, long-acting, drug-free pain control using precise, controlled doses of cold temperature to a targeted nerve.